SecBot SecBot
10-Q/A ·Filed Apr 15, 2026
QG

QGAI

Quantum Genesis AI Corp.
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago SEC0001477932-26-002256
Amended quarterly report (potential restatement)
Actionable Insight • Neutral

No trading implication from this filing; it is a procedural disclosure update. However, traders should note the prior late filing and ongoing going concern uncertainty as potential red flags for operational and financial stability.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
QGAI ▼ -30.95% at T+60d
NEUTRAL call -30.95% · α vs SPY -39.09% · entry $0.2100 → $0.1450
Entry = T+0 close
Apr 15, 2026
via day close
T+1d
-69.05%
call -69.05% · α -69.30%
$0.0650
settled 6mo ago
T+5d
-42.86%
call -42.86% · α -44.50%
$0.1200
settled 6mo ago
T+20d
-59.52%
call -59.52% · α -65.57%
$0.0850
settled 6mo ago
T+60d
-30.95%
call -30.95% · α -39.09%
$0.1450
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Quantum Genesis AI Corp. filed an amended 10-Q/A solely to add disclosure about intellectual property formalization via an Assignment Agreement with its CEO, retroactively effective to November 2023. No financial statements were restated or corrected. This follows a prior late filing (NT 10-K) due to delays in finalizing financials.

Key Facts

  • Amendment No. 1 to 10-Q for period ended October 31, 2025, filed April 15, 2026, solely to update Item 2 (MD&A) with additional intellectual property disclosure.
  • No changes were made to financial statements, notes, or other financial disclosures.
  • The Company formalized IP transfer from CEO via Assignment Agreement effective November 2, 2023, covering patent application US20250146029A1 for enzymatic synthesis of ibuprofen.
  • Company previously filed NT 10-K on October 28, 2025, citing inability to file annual report without unreasonable effort or expense.

Financial Impact

No financial impact — amendment did not revise any financial statements or metrics.

Risk Factors

  • Substantial doubt about the company's ability to continue as a going concern due to accumulated deficits and recurring losses.
  • History of late filings (NT 10-K) raises concerns about internal controls and reporting reliability.

Market Snapshot

Exchange
OTC
Sector
Industrial Organic Chemicals

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
10-Q/A Filing (Primary)0001477932-26-002256
Document: qtzm_ex311.htm0001477932-26-002256
Document: qtzm_ex321.htm0001477932-26-002256
Document: 0001477932-26-002256-index-headers.html0001477932-26-002256
Document: 0001477932-26-002256-index.html0001477932-26-002256
Document: 0001477932-26-002256.txt0001477932-26-002256
4 reports for QGAI
Performance horizon
Filters
Rows
Reports for QGAI — sortable, filterable
TypeNow
Apr 15, 2026
27w ago
10-Q/A
NEUTRAL ★ 3/10
$0.2100 $0.0850▼ −59.52%▼ −65.57%$0.0300 (−85.71%)
Apr 15, 2026
27w ago
10-Q/A
NEUTRAL ★ 3/10
$0.2100 $0.0850▼ −59.52%▼ −65.57%$0.0300 (−85.71%)
Apr 15, 2026
27w ago
10-K/A
NEUTRAL ★ 5/10
$0.2100 $0.0850▼ −59.52%▼ −65.57%$0.0300 (−85.71%)
Apr 15, 2026
27w ago
8-K
NEUTRAL ★ 3/10
$0.2100 $0.0850▼ −59.52%▼ −65.57%$0.0300 (−85.71%)
Showing 4 of 4

US Market Status

Market Closed — Opens Wed (13h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 15, 2026